ABUS

Arbutus Biopharma (ABUS)

Arbutus Biopharma Corporation

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:ABUS

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/09	21:00	Edgar (US Regulatory)	Form SC 13D - General statement of acquisition of beneficial ownership	NASDAQ:ABUS	Arbutus Biopharma Corporation
2024/05/07	20:30	GlobeNewswire Inc.	Arbutus to Participate in Two Upcoming Investor Conferences	NASDAQ:ABUS	Arbutus Biopharma Corporation
2024/05/02	20:30	GlobeNewswire Inc.	Arbutus Reports First Quarter 2024 Financial Results and Provides Corporate Update	NASDAQ:ABUS	Arbutus Biopharma Corporation
2024/05/02	20:25	GlobeNewswire Inc.	Arbutus Announces Retirement of Chief Scientific Officer, Michael J. Sofia, PhD, Effective December 31, 2024	NASDAQ:ABUS	Arbutus Biopharma Corporation
2024/04/18	20:30	GlobeNewswire Inc.	Arbutus to Report First Quarter 2024 Financial Results and Provide Corporate Update	NASDAQ:ABUS	Arbutus Biopharma Corporation
2024/04/04	21:30	GlobeNewswire Inc.	Arbutus Biopharma Announces Claim Construction Ruling in its Ongoing Patent Infringement Lawsuit Against Moderna	NASDAQ:ABUS	Arbutus Biopharma Corporation
2024/03/08	21:30	GlobeNewswire Inc.	Arbutus to Participate in Two Upcoming Investor Conferences	NASDAQ:ABUS	Arbutus Biopharma Corporation
2024/03/06	06:48	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:ABUS	Arbutus Biopharma Corporation
2024/02/29	21:31	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ABUS	Arbutus Biopharma Corporation
2024/02/29	21:30	GlobeNewswire Inc.	Arbutus Reports Fourth Quarter and Year End 2023 Financial Results and Provides Corporate Update	NASDAQ:ABUS	Arbutus Biopharma Corporation
2024/02/15	21:30	GlobeNewswire Inc.	Arbutus to Report Fourth Quarter and Year End 2023 Financial Results and Provide Corporate Update	NASDAQ:ABUS	Arbutus Biopharma Corporation
2024/02/15	06:38	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:ABUS	Arbutus Biopharma Corporation
2024/02/15	00:48	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:ABUS	Arbutus Biopharma Corporation
2024/02/06	09:55	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ABUS	Arbutus Biopharma Corporation
2024/02/06	09:55	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ABUS	Arbutus Biopharma Corporation
2024/02/06	09:54	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ABUS	Arbutus Biopharma Corporation
2024/02/06	09:54	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ABUS	Arbutus Biopharma Corporation
2024/01/08	21:31	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ABUS	Arbutus Biopharma Corporation
2024/01/08	21:30	GlobeNewswire Inc.	Arbutus Announces 2024 Corporate Objectives and Provides Financial Update	NASDAQ:ABUS	Arbutus Biopharma Corporation
2024/01/05	06:09	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ABUS	Arbutus Biopharma Corporation
2023/11/21	22:00	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:ABUS	Arbutus Biopharma Corporation
2023/11/10	06:02	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ABUS	Arbutus Biopharma Corporation
2023/11/08	21:30	GlobeNewswire Inc.	Arbutus to Present at Jefferies London Healthcare Conference	NASDAQ:ABUS	Arbutus Biopharma Corporation
2023/11/08	06:18	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:ABUS	Arbutus Biopharma Corporation
2023/11/07	21:31	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ABUS	Arbutus Biopharma Corporation
2023/11/07	21:30	GlobeNewswire Inc.	Arbutus Reports Third Quarter 2023 Financial Results and Provides Corporate Update	NASDAQ:ABUS	Arbutus Biopharma Corporation
2023/11/07	21:16	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ABUS	Arbutus Biopharma Corporation
2023/11/07	21:15	GlobeNewswire Inc.	Arbutus Announces CEO, William Collier, to Retire December 31, 2023	NASDAQ:ABUS	Arbutus Biopharma Corporation
2023/10/24	20:30	GlobeNewswire Inc.	Arbutus to Report Third Quarter 2023 Financial Results and Provide Corporate Update	NASDAQ:ABUS	Arbutus Biopharma Corporation
2023/10/18	20:30	GlobeNewswire Inc.	Arbutus to Present at H.C. Wainwright 4th Annual Hepatitis B Virus (HBV) Virtual Conference	NASDAQ:ABUS	Arbutus Biopharma Corporation